Pregled bibliografske jedinice broj: 25978
Current Differential Diagnosis of Multiple Sclerosis
Current Differential Diagnosis of Multiple Sclerosis // Acta clinica Croatica / Demarin, Vida ; Trkanjec, Zlatko (ur.).
Zagreb: Klinički bolnički centar Sestre milosrdnice, 1997. str. 62-64 (predavanje, domaća recenzija, cjeloviti rad (in extenso), stručni)
CROSBI ID: 25978 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Current Differential Diagnosis of Multiple Sclerosis
Autori
Sepčić, Juraj ; Rudež, Josip ; Willheim, Ksenija ; Weiner-Črnja, Mima
Vrsta, podvrsta i kategorija rada
Radovi u zbornicima skupova, cjeloviti rad (in extenso), stručni
Izvornik
Acta clinica Croatica
/ Demarin, Vida ; Trkanjec, Zlatko - Zagreb : Klinički bolnički centar Sestre milosrdnice, 1997, 62-64
Skup
Second Croatian Congress of Neurology
Mjesto i datum
Zagreb, Hrvatska, 14.05.1997. - 17.05.1997
Vrsta sudjelovanja
Predavanje
Vrsta recenzije
Domaća recenzija
Ključne riječi
Multiple sclerosis; diagnosis
Sažetak
The diseases that are likely to be misdiagnosed as MS, can be grouped as follows: Diseases that cause multiple CNS lesions, even characterized by a remitent-exacerbating course; Systemic CNS diseases that frequently cause lesions to separate nerve axis segments, but with regular, usually symmetrical events and progressive course; CNS lesions with remitend-exacerbating course; CNS lesions with progressive course; Monosymptomatic manifestation of MS; Somatization disorders. The current methods of neuroimaging, evoked potentials and cerebrospinal fluid immunology restrict the possibility of erroneous MS diagnosis. However, none of these procedures is specific.
History data and or clinical evidence of dissemination of CNS lesions in time and space remain the key elements for a physician to make positive conclusions on the diagnosis of MS. Neuroepidemiologic and clinical studies of MS in Croatia have shown the percentage of erroneous diagnosis of MS to be higher, i.e. about 35 percent.
Only the diagnosis of clinically deffinite and laboratory supported MS allows proper treatment of MS patients and prevents the risk of the results of neuroepidemiologic studies and clinical trials on the disease to be loaded with erroneous and unreliable data.
Izvorni jezik
Engleski
Znanstvena područja
Javno zdravstvo i zdravstvena zaštita